Tag: WuXi ATU

Innovation, Med Tech

WuXi ATU launches new technology to produce gene therapies

March 8, 2022


WuXi AppTec’s wholly-owned subsidiary WuXi Advanced Therapies (WuXi ATU) has announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology to improve scalability and accessibility of cell and gene therapies. The new technology, which is developed by Oxgene, offers a scalable […]